Results may help Merck expand use of Vytorin
Marc Iskowitz
November 23 2010
Based on positive results of Vytorin (ezetimibe/simvastatin) in patients with chronic kidney disease (CKD), Merck said it will apply for ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.